Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia

IMPORTANCE: Use of empirical broad-spectrum antibiotics for pneumonia has increased owing to concern for resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA). The association of empirical anti-MRSA therapy with outcomes among patients with pneumonia is unknown, even for...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:JAMA Intern Med
मुख्य लेखकों: Jones, Barbara Ellen, Ying, Jian, Stevens, Vanessa, Haroldsen, Candace, He, Tao, Nevers, McKenna, Christensen, Matthew A., Nelson, Richard E., Stoddard, Gregory J., Sauer, Brian C., Yarbrough, Peter M., Jones, Makoto M., Goetz, Matthew Bidwell, Greene, Tom, Samore, Matthew H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Medical Association 2020
विषय:
Original Investigation
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042818/
https://ncbi.nlm.nih.gov/pubmed/32065604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.7495
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन